JP2024512986A5 - - Google Patents
Info
- Publication number
- JP2024512986A5 JP2024512986A5 JP2023559766A JP2023559766A JP2024512986A5 JP 2024512986 A5 JP2024512986 A5 JP 2024512986A5 JP 2023559766 A JP2023559766 A JP 2023559766A JP 2023559766 A JP2023559766 A JP 2023559766A JP 2024512986 A5 JP2024512986 A5 JP 2024512986A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- ring atoms
- group
- alkenyl
- heteroatoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163167915P | 2021-03-30 | 2021-03-30 | |
| US63/167,915 | 2021-03-30 | ||
| EP21305405 | 2021-03-30 | ||
| EP21305405.9 | 2021-03-30 | ||
| PCT/EP2022/058402 WO2022207699A1 (en) | 2021-03-30 | 2022-03-30 | Enzyme-triggered self-reacting linker having improved physicochemical and pharmacological properties |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512986A JP2024512986A (ja) | 2024-03-21 |
| JP2024512986A5 true JP2024512986A5 (enExample) | 2025-04-02 |
Family
ID=81580241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559766A Pending JP2024512986A (ja) | 2021-03-30 | 2022-03-30 | 改良された物理化学的特性および薬理学的特性を有する酵素トリガー自己反応性リンカー |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240216525A1 (enExample) |
| EP (1) | EP4313157A1 (enExample) |
| JP (1) | JP2024512986A (enExample) |
| KR (1) | KR20230165288A (enExample) |
| AU (1) | AU2022248565A1 (enExample) |
| BR (1) | BR112023019495A2 (enExample) |
| CA (1) | CA3215279A1 (enExample) |
| IL (1) | IL306050A (enExample) |
| MX (1) | MX2023011630A (enExample) |
| WO (1) | WO2022207699A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116390771A (zh) | 2020-07-13 | 2023-07-04 | 瑞泽恩制药公司 | 与蛋白中的谷氨酰胺残基缀合的喜树碱类似物及其用途 |
| CA3241734A1 (en) * | 2022-01-12 | 2023-07-20 | Amy Han | Camptothecin analogs conjugated to a glutamine residue in a protein, and their use |
| PE20251386A1 (es) * | 2022-03-11 | 2025-05-22 | Mablink Bioscience | Conjugados anticuerpo-farmaco y sus usos |
| WO2024149345A1 (en) * | 2023-01-11 | 2024-07-18 | Profoundbio Us Co. | Linkers, drug linkers and conjugates thereof and methods of using the same |
| WO2024222841A1 (zh) * | 2023-04-27 | 2024-10-31 | 石药集团巨石生物制药有限公司 | 一种抗体药物偶联物 |
| AU2024263367A1 (en) * | 2023-04-27 | 2025-11-13 | CSPC Megalith Biopharmaceutical Co., Ltd. | Antibody-drug conjugate |
| EP4512427A1 (en) | 2023-08-25 | 2025-02-26 | Mablink Bioscience | Antibody-drug conjugates based on molecular glue degraders and uses thereof |
| EP4534101A1 (en) | 2023-10-02 | 2025-04-09 | Eli Lilly and Company | Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload |
| EP4534102A1 (en) | 2023-10-02 | 2025-04-09 | Eli Lilly and Company | Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload |
| FR3155709A1 (fr) * | 2023-11-27 | 2025-05-30 | Skymab Biotherapeutics | Conjugue anticorps-medicament et ses utilisations |
| FR3155708A1 (fr) * | 2023-11-27 | 2025-05-30 | Skymab Biotherapeutics | Conjugue anticorps-medicament et ses utilisations |
| EP4566631A1 (en) | 2023-12-06 | 2025-06-11 | Heidelberg Pharma Research GmbH | New antibody drug conjugate as well as methods of production and uses thereof |
| WO2025230926A1 (en) * | 2024-04-29 | 2025-11-06 | Obi Pharma, Inc. | Improved linker-payloads for antibody conjugation, pharmaceutical compositions and applications thereof |
| WO2026076215A1 (en) * | 2024-10-03 | 2026-04-09 | Solve Therapeutics, Inc. | Conjugates and uses thereof |
| WO2026085106A1 (en) * | 2024-10-15 | 2026-04-23 | Solve Therapeutics, Inc. | Conjugates and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2960153B1 (fr) | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
| AU2016359235B2 (en) | 2015-11-25 | 2022-09-15 | Ligachem Biosciences Inc. | Antibody-drug conjugates comprising branched linkers and methods related thereto |
| JP7381478B2 (ja) | 2017-10-23 | 2023-11-15 | マブリンク ビオシオンス | 単一分子量ポリサルコシンを含むリガンド－薬物－複合体 |
-
2022
- 2022-03-30 BR BR112023019495A patent/BR112023019495A2/pt unknown
- 2022-03-30 MX MX2023011630A patent/MX2023011630A/es unknown
- 2022-03-30 US US18/285,175 patent/US20240216525A1/en active Pending
- 2022-03-30 CA CA3215279A patent/CA3215279A1/en active Pending
- 2022-03-30 JP JP2023559766A patent/JP2024512986A/ja active Pending
- 2022-03-30 WO PCT/EP2022/058402 patent/WO2022207699A1/en not_active Ceased
- 2022-03-30 EP EP22720929.3A patent/EP4313157A1/en active Pending
- 2022-03-30 AU AU2022248565A patent/AU2022248565A1/en active Pending
- 2022-03-30 IL IL306050A patent/IL306050A/en unknown
- 2022-03-30 KR KR1020237037385A patent/KR20230165288A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024512986A5 (enExample) | ||
| JP7644173B2 (ja) | 単一分子量ポリサルコシンを含むリガンド－薬物－複合体 | |
| JP7430643B2 (ja) | カンプトテシンペプチドコンジュゲート | |
| JP7429987B2 (ja) | 架橋ピロロベンゾジアゼピン二量体（ｐｂｄ）誘導体及びその共役体 | |
| IL306050A (en) | Enzyme-triggered self-reacting linker having improved physicochemical and pharmacological properties | |
| JP2024099041A5 (enExample) | ||
| JP7138350B2 (ja) | 共役連結体、該連結体を含有する細胞結合分子－薬物共役体、並びに該共役体及び連結体の使用及び製造方法 | |
| JP5350586B2 (ja) | ヘテロ二官能性重合体生物複合体 | |
| DK2678037T3 (en) | Branched linker for protein pharmaceutical conjugates | |
| JP2025510629A (ja) | カンプトテシンコンジュゲート | |
| JP7814303B2 (ja) | 内部移行した生物学的に活性な化合物の結合体からの選択的な薬物放出 | |
| JP2023530128A (ja) | 細胞結合分子とカンプトテシン類縁体との共役体 | |
| JP2021527040A (ja) | カンプトテシンコンジュゲート | |
| JP2019502650A5 (ja) | 抗ＥｒｂＢ２抗体−薬物コンジュゲート及びその組成物、そのための調製方法、並びにその使用 | |
| JP2023010733A (ja) | γ－アマニチンの誘導体 | |
| JP2023514275A (ja) | 標的化された送達の用途のための線維芽細胞活性化タンパク質リガンド | |
| CN104884056A (zh) | 用于制备缀合物的化合物和方法 | |
| JP2017501128A (ja) | ヒドラジニル−ピロロ化合物及び複合体を生成するための方法 | |
| JP2022126826A (ja) | ヘテロアリールスルホンをベースとするコンジュゲーションハンドル、これらの調製のための方法、および抗体薬物コンジュゲートの合成におけるこれらの使用 | |
| JP2022172122A (ja) | 細胞結合分子の共役のための架橋連結体 | |
| CN112839683A (zh) | 含有标记部-抗人抗体Fab片段复合物的药物组合物 | |
| JP2023504825A (ja) | 反応性コンジュゲート | |
| JP2024529466A5 (enExample) | ||
| JP2023159139A (ja) | 新規な連結体及び生体分子と薬物との特異的共役におけるその使用 | |
| KR960701667A (ko) | 2작용기성 킬레이트제, 그 테크네튬 및 레늄 착물과 이들의 제조방법 및 이들 화합물을 함유하는 방사성 약물 |